Immuneering Corp. (IMRX)
5.45
+0.12
(+2.25%)
USD |
NASDAQ |
Apr 02, 16:00
5.50
+0.05
(+0.92%)
Pre-Market: 08:20
Immuneering Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -246.8% |
| Verastem, Inc. | -187.7% |
| Phathom Pharmaceuticals, Inc. | -36.73% |
| Tango Therapeutics, Inc. | -- |
| X4 Pharmaceuticals, Inc. | -931.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.15% |
| Return on Assets | -45.44% |
| Return on Invested Capital | -48.41% |
| Return on Net Operating Assets | -486.5% |